MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma

被引：0
|
作者：
Yu-Xiang Lin
Jun-Yong Pan
Wen-Du Feng
Tian-Cong Huang
Cheng-Zong Li
机构：
[1] The Second Affiliated Hospital of Fujian Medical University (Donghai District),Department of Hepatobiliary and Pancreatic Surgery
[2] The Second Affiliated Hospital of Fujian Medical University,Central Supply Service Department
来源：
European Journal of Medical Research | / 28卷
关键词：
Hepatocellular carcinoma; MRPL48; Prognostic value; Biomarker; Biological functions;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] NOVEL EPIGENETIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA
    Luna, Aesis
    Algarrahi, Khalid
    Yin, Zhiwei
    Matti, Nawar
    Badeti, Saiaditya
    Rustgi, Vinod K.
    Hlady, Ryan
    Robertson, Keith
    Liu, Chen
    HEPATOLOGY, 2019, 70 : 1150A - 1150A
  • [42] Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma
    Gao, Xiaoge
    Ren, Xin
    Wang, Feitong
    Ren, Xinxin
    Liu, Mengchen
    Cui, Guozhen
    Liu, Xiangye
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [43] CD24 as a Novel Predictive Biomarker in Patients with Hepatocellular Carcinoma: Friend or Foe?
    Machairas, Nikolaos
    Tsilimigras, Diamantis I.
    Moris, Demetrios
    JOURNAL OF INVESTIGATIVE SURGERY, 2020, 33 (06) : 542 - 543
  • [44] Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma
    Liu, Tiantian
    Qi, Jianni
    Wu, Hao
    Wang, Le
    Zhu, Lihui
    Qin, Chengyong
    Zhang, Jiao
    Zhu, Qiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
    Isaac, Amira
    Mohamed, Sherif Mounir
    Ahmed, Osama Ashraf
    Hassan, Ahmed Gamal Mohamed
    Rasmy, Hany Samir
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2021, 33 (01):
  • [46] Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
    Amira Isaac
    Sherif Mounir Mohamed
    Osama Ashraf Ahmed
    Ahmed Gamal Mohamed Hassan
    Hany Samir Rasmy
    The Egyptian Journal of Internal Medicine, 2021, 33
  • [47] A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma
    Zhu, Pengpeng
    Jin, Junfei
    Liao, Yan
    Li, Jun
    Yu, Xue-Zhong
    Liao, Weijia
    He, Songqing
    ONCOTARGET, 2015, 6 (38) : 41383 - 41397
  • [48] CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis
    Peng, Fei
    Li, Hui
    You, Qian
    Li, Hongru
    Wu, Dongwen
    Jiang, Chunxiang
    Deng, Guangtong
    Li, Yan
    Li, Yuyan
    Wu, Yi
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [49] Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma
    Sui, Jing
    Miao, Yan
    Han, Jiali
    Nan, Hongmei
    Shen, Bo
    Zhang, Xiaomei
    Zhang, Yan
    Wu, Yuan
    Wu, Wenjuan
    Liu, Tong
    Xu, Siyi
    Yang, Sheng
    Yin, Lihong
    Pu, Yuepu
    Liang, Geyu
    CANCER MEDICINE, 2018, 7 (07): : 3240 - 3256
  • [50] Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
    Dupuy, Marie
    Iltache, Sarah
    Riviere, Benjamin
    Prieur, Alexandre
    Pageaux, George Philippe
    Bedoya, Jose Ursic
    Faure, Stephanie
    Guillaumee, Heloise
    Assenat, Eric
    CANCERS, 2022, 14 (02)
12345